[Multiple autoantibodies in the course of Hodgkin's disease: interpretation of erythroblastopenia].
D000293:Adolescent; D000743:Anemia, Hemolytic / Q000209:etiology / Q000628:therapy; D001323:Autoantibodies / Q000032:analysis*; D001327:Autoimmune Diseases / Q000150:complications; D001623:Betamethasone / Q000627:therapeutic use; D001792:Blood Platelets; D001803:Blood Transfusion; D001856:Bone Marrow Examination; D001963:Bromelains; D003298:Coombs Test; D004906:Erythrocyte Count; D004912:Erythrocytes / Q000276:immunology*; D005455:Fluorescent Antibody Technique; D006386:Hemagglutination Tests; D006689:Hodgkin Disease / Q000150:complications / Q000276:immunology*; D006801:Humans; D007122:Immunoelectrophoresis; D007958:Leukocyte Count; D008297:Male; D012156:Reticulocytes; D013921:Thrombocytopenia / Q000188:drug therapy
D001323:Autoantibodies; D001963:Bromelains; D001623:Betamethasone
Auto-anticorps multiples au cours d'une maladie de Hodgkin: interprétation d'une érythroblastopénie.